Skip to main content
Preclinical Animal Telemetry Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, Japan - Size and Forecast 2024-2028

Preclinical Animal Telemetry Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, Japan - Size and Forecast 2024-2028

Published: Jan 2024 152 Pages SKU: IRTNTR44979

Market Overview at a Glance

$21.55 Mn
Market Opportunity
5.69%
CAGR
4.86
YoY growth 2023-2024(%)

Preclinical Animal Telemetry Market 2024-2028

The global preclinical animal telemetry market size is estimated to grow by USD 21.55 million at a CAGR of 5.69% between 2023 and 2028.  

As a part of organic growth strategies, companies are increasingly focusing on new feature integration, as well as product development and launches. The launch of new products is allowing companies to remain competitive in the market by offering the latest available technologies to their customers. Additionally, companies can efficiently meet the specific demands of end-users by bringing innovative changes in their product lineup as per customers' expectations. Some of the recent product launches have been discussed below: Since 2021, the US Animal Telemetry Network (ATN) has been attempting to integrate ocean profiles obtained from animal-borne satellite telemetry tags, including the Wildlife Computers SCOUT-CTD, into the World Meteorological Organizations Global Telecommunication System. Such constant improvements and upgrades in features have brought significant differentiation in products and have helped companies lower the competition and increase product penetration. Therefore, an increase in product launches of preclinical animal telemetry is driving the market growth during the forecast period. 

Technavio has segmented the market into End-user, Type, and Geography 

  • The end-user segment is classified into industrial laboratories and CROs, academic government, and other research laboratories
  • The type  segment is classified into small animal telemetry and large animal telemetry
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Animal Telemetry Market During the Forecast Period?

Preclinical Animal Telemetry Market Size

To learn more about this report, Download Report Sample

Preclinical Animal Telemetry Market Segmentation by End-user, Type and Geography Analysis

End-user Analysis

Industrial laboratories and CROs

The market share growth by the industrial laboratories and CROs segment will be significant during the forecast period. Industrial laboratories (including pharmaceutical and biotechnology companies) and CROs are among the key organizations involved in drug discovery, research, design, and development. These organizations spend a considerable number of resources and time in preclinical and clinical research for advancing new therapeutic candidates. 

Preclinical Animal Telemetry Market Size

Get a glance at the market contribution of various segments Download PDF Sample

The Industrial laboratories and CROs were the largest segment and were valued at USD 32.41 million in 2018. Further, the increase in patent expiries of blockbuster drugs and biologicals has led to an increased focus on R&D activities. As a result, pharmaceutical and biotechnology companies are increasingly promoting the outsourcing of clinical research to CROs. This led to the outsourcing of R&D activities for developing new formulations. To reduce the risk of adverse events during clinical trials of these new formulations, the demand for preclinical animal testing, including toxicology testing and cosmetic testing, has increased. Animal telemetry solutions are finding extensive use for collecting and analyzing a large amount of preclinical safety and efficacy data. This preclinical safety and efficacy data is required to be submitted to drug regulatory authorities before permission for further studies in humans is granted. As a result, significant demand for preclinical animal research and testing can be observed across industrial laboratories and CROs globally, which is driving the adoption of animal telemetry systems, which, in turn, will drive the growth of the market during the forecast period.

Type Analysis

Small animal telemetry

The small animal telemetry segment includes animal telemetry solutions that are used in preclinical research with small animals such as mice, rabbits, ferrets, rats, hamsters, and Guinea pigs. Small animal telemetry solutions are usually miniaturized telemetry implants that are small in size and lightweight and can be custom-configured and modified as per the research and testing requirements. Furthermore, the availability of cost-effective, minimally invasive, wireless battery charging-based, flexible telemetry systems is adding to the growing sales of small animal telemetry systems. The market is expected to witness swift growth owing to stringencies in regulations for maintaining pharmacological safety and the growing availability of funding for research related to neuroscience, cardiology, and oncology.

Regional Analysis

Preclinical Animal Telemetry Market Share by Geography

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America dominates the global preclinical animal telemetry market, with the US and Canada as leading revenue-generating countries. Increasing growth in drug and vaccine approvals and growth in investments for drug research and development surged the demand for animal testing during preclinical studies. As a result, the demand for animal telemetry systems witnessed significant growth in the region. Furthermore, the presence of a large number of prominent players, such as BIOPAC Systems, Indus Instruments, Harvard Biosciences, Somark Innovations, TSE Systems GMBH, Starr Life Sciences Corp., and Transonic, helped in ensuring the easy availability of advanced telemetry solutions among end-users.

Furthermore, the exceptional veterinary-specific equipment offered by Mindray Animal Medical ranges from the ePM series monitors or the TM80 Vet telemetry to a central station for vital sign monitoring, the Veta 5 and WATO series anesthesia station with integrated ventilators, and the BeneFusion VP3 Vet and BeneFusion SP3 Vet fluid pumps. These products are designed to support and elevate standards in animal health care. Therefore such factors are expected to drive the regional market growth during the forecast period. 

Buy the Full Report Now

Key Preclinical Animal Telemetry Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

ADInstruments Pty Ltd.: The company offers preclinical animal telemetry for the wireless recording of a variety of biological signals in small animals under its brand Kaha Sciences.

  • ADInstruments Pty Ltd.
  • Advanced Telemetry Systems Inc.
  • BIO RESEARCH CENTER Co. Ltd.
  • BIOPAC Systems Inc.
  • Cambridge NeuroTech
  • Charles River Laboratories International Inc.
  • Ecotone Goc
  • emka TECHNOLOGIES
  • ETISENSE SAS
  • Harvard Bioscience Inc.
  • Indus Instruments, Instem Plc
  • Kent Scientific Corp.
  • Muromachi Kikai Co. Ltd.
  • Somark Innovations
  • Star Oddi hf

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Preclinical Animal Telemetry Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market research and growth analysis. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges. 

Key Preclinical Animal Telemetry Market Drivers

Increasing growth in preclinical research and testing is notably driving the market growth. The rising prevalence of diseases such as cardiovascular diseases, endocrine and metabolic disorders, cancer, and diabetes across the globe has stimulated the demand for the development of efficient and effective therapeutics. As a result, increasing market growth and trends in preclinical and clinical research activities across pharmaceutical companies and CROs can be observed. Furthermore, the competition among drug developers is high, and to gain a competitive edge, these organizations are rapidly adopting advanced and automated workflows in their routine processes.

Thus, the demand for animal telemetry systems in preclinical research has increased. These systems offer automated and real-time monitoring of the physiological activities of small and large animal models. Such capabilities are enhancing drug development studies and are ensuring the rapid development of drugs, thereby driving the adoption of animal telemetry solutions among pharmaceutical companies and CROs. Thus, such factors will drive the growth of the market during the market forecast period.

Significant Preclinical Animal Telemetry Market Trends

Growing focus on developing SEND-compatible software is an emerging trend shaping the market growth. Modifications in US FDA regulatory requirements for data submission have brought significant changes across product lines since January 2019. To overcome inconsistencies in data formats and to define standard data format for nonclinical data presentation, the US FDA has mandated the use of the Standard of Exchange of Nonclinical Data (SEND) format, which specifies a way to present nonclinical data. Further, the availability of easy report-generating capabilities in a defined SEND format allows end-users to comply with defined standards for submitting preclinical data to the US FDA quickly and without manual efforts.

As a result, the demand for software that supports SEND-compatible output has increased among end-users. Thus, the growing focus on developing SEND-compatible software will drive the growth of the global preclinical animal telemetry market during the forecast period.

Major Preclinical Animal Telemetry Market Challenges

Limitations associated with animal telemetry systems are a significant challenge hindering market growth. Animal telemetry systems are extensively used in preclinical studies as an advanced and innovative technique for physiological monitoring and data collection of animal models. However, these systems have certain technical challenges and limitations which hamper their sales. Some of the common issues are the limited battery life of telemetric implants, poor design and scalability, bandwidth-related issues, and the lack of compatibility. Furthermore, the integration of animal telemetry hardware and software into the existing systems of laboratories is another challenge. A laboratory may operate different kinds of systems, including computers and laboratory equipment, which may not be compatible with advanced offerings from vendors.

However, such laboratory settings prefer the use of conventional systems, which lowers the adoption of new and improved systems, thereby hampering the sales of new animal telemetry systems. Thus, limitations associated with animal telemetry systems will hamper the growth of the market during the forecast period.

Buy Now Full Report

Key Preclinical Animal Telemetry Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Preclinical Animal Telemetry Market Share by Geography

Global Preclinical Animal Telemetry Market Customer Landscape

Segment Overview

The preclinical animal telemetry market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and market growth and forecasting opportunities from 2018 to 2028. 

  • End-user Outlook
    • Industrial laboratories and CROs
    • Academic government and
    • Other research laboratories
  • Type Outlook
    • Small animal telemetry
    • Large animal telemetry
    Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Australia

Preclinical Animal Telemetry Market Scope

Report Coverage

Details

Page number

152

Base year

2023

Historic period

2018-2022

Market forecasting period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.69%

Market Growth 2024-2028

USD 21.55 million

Market structure

Fragmented

YoY growth 2023-2024(%)

4.86

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, UK, Germany, France, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

ADInstruments Pty Ltd., Advanced Telemetry Systems Inc., BIO RESEARCH CENTER Co. Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, Charles River Laboratories International Inc., Ecotone Goc, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Plc, Kent Scientific Corp., Muromachi Kikai Co. Ltd., Somark Innovations, Star Oddi hf, Starr Life Sciences Corp., Telemetry Solutions Inc., TSE Systems GmbH, and Vivonics Preclinical Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Preclinical Animal Telemetry Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the preclinical animal telemetry market between 2024 and 2028

  • Precise estimation of the preclinical animal telemetry market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of preclinical animal telemetry market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Preclinical Animal Telemetry market growth will increase by $ 21.55 mn during 2024-2028.

The Preclinical Animal Telemetry market is expected to grow at a CAGR of 5.69% during 2024-2028.

Preclinical Animal Telemetry market is segmented by End-user( Industrial laboratories and CROs, Academic government, other research laboratories, other research laboratories) Type( Small animal telemetry, Large animal telemetry)

ADInstruments Pty Ltd., Advanced Telemetry Systems Inc., BIO RESEARCH CENTER Co. Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, Charles River Laboratories International Inc., Ecotone Goc, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Plc, Kent Scientific Corp., Muromachi Kikai Co. Ltd., Somark Innovations, Star Oddi hf, Starr Life Sciences Corp., Telemetry Solutions Inc., TSE Systems GmbH, Vivonics Preclinical Ltd. are a few of the key vendors in the Preclinical Animal Telemetry market.

North America will register the highest growth rate of 44% among the other regions. Therefore, the Preclinical Animal Telemetry market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, UK, Germany, France, Japan

  • Increasing growth in preclinical research and testingThe rising prevalence of diseases such as cardiovascular diseases is the driving factor this market.
  • endocrine and metabolic disorders is the driving factor this market.
  • cancer is the driving factor this market.
  • and diabetes across the globe has stimulated the demand for the development of efficient and effective therapeutics. As a result is the driving factor this market.
  • increasing growth in preclinical and clinical research activities across pharmaceutical companies and CROs can be observed. In addition is the driving factor this market.
  • the emergence of advanced omics-based technologies such as genomics is the driving factor this market.
  • proteomics is the driving factor this market.
  • and metabolomics and their use in developing a promising therapeutic candidate has garnered the attention of many public and private funding organizations is the driving factor this market.
  • which are increasingly investing in various drug development and research projects across the globe. Growth in pharmaceutical research and testing has resulted in the launch of new drug candidates and biosimilars. To ensure the safety of new drug formulations is the driving factor this market.
  • the reliance on animal model-based preclinical testing has increased. Preclinical animal studies help in generating critical information for designing and performing clinical trials is the driving factor this market.
  • as such studies provide evidence of a drugs potential clinical utility and establish an ethical basis for testing drugs in humans. After the completion of The Human Genome Project in 2000 is the driving factor this market.
  • the studies related to gene mapping and gene function validations on live animal models for identifying new gene sequences and targeted gene mutations are witnessing a sharp surge. Additionally is the driving factor this market.
  • the availability of disease models is the driving factor this market.
  • such as polygenic disease models is the driving factor this market.
  • specifically for cancer studies is the driving factor this market.
  • is witnessing rapid adoption among pharmaceutical companies and CROs. The competition among drug developers is high is the driving factor this market.
  • and in order to gain a competitive edge is the driving factor this market.
  • these organizations are rapidly adopting advanced and automated workflows in their routine processes. As a result is the driving factor this market.
  • the demand for animal telemetry systems in preclinical research has increased. These systems offer automated and real-time monitoring of the physiological activities of small and large animal models. Such capabilities are enhancing drug development studies and are ensuring the rapid development of drugs is the driving factor this market.
  • thereby driving the adoption of animal telemetry solutions among pharmaceutical companies and CROs. Thus is the driving factor this market.
  • the increasing growth in preclinical research and testing will drive the growth of the global preclinical animal telemetry market during the forecast period. is the driving factor this market.

The Preclinical Animal Telemetry market vendors should focus on grabbing business opportunities from the Industrial laboratories and CROs segment as it accounted for the largest market share in the base year.